Drug Price Trends for PEG3350-SOD SUL-NACL-KCL-ASCB-C

Average Pharmacy Cost for PEG3350-SOD SUL-NACL-KCL-ASCB-C

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G	68682-0201-75	69.72072	EACH	2025-03-19
PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G	00093-3560-26	69.72072	EACH	2025-03-19
PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G	68682-0201-75	63.13371	EACH	2025-02-19
PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G	00093-3560-26	63.13371	EACH	2025-02-19
PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G	68682-0201-75	61.09994	EACH	2025-01-22

Market Analysis and Price Projections for PEG3350-SOD SUL-NACL-KCL-ASCB-C

Introduction to PEG3350-SOD SUL-NACL-KCL-ASCB-C

PEG3350-SOD SUL-NACL-KCL-ASCB-C, a formulation of polyethylene glycol 3350 (PEG 3350) combined with electrolytes such as sodium sulfate, sodium chloride, potassium chloride, and ascorbic acid, is a widely used osmotic laxative. This medication is primarily used to clean out the intestines before procedures like colonoscopies and other medical tests.

Market Overview

The PEG 3350 market, which includes formulations like PEG3350-SOD SUL-NACL-KCL-ASCB-C, is expected to experience significant growth in the coming years.

• Market Size and Growth: The PEG 3350 market is projected to grow from USD 2.08 billion in 2024 to USD 3.71 billion by 2032, exhibiting a compound annual growth rate (CAGR) of around 7-8% during this period[1].

Product Types and Applications

• Product Types: The market is segmented into powder and bowel preparation kit forms. The powder form, which needs to be reconstituted with water, is the most common[1].
• Applications: The primary applications include treatment of constipation, preparation for medical tests such as colonoscopies and barium enema X-ray examinations, and pre-surgical bowel preparation[1].

Distribution Channels

• Online and Offline Pharmacies: The distribution channels for PEG3350-SOD SUL-NACL-KCL-ASCB-C include both online and offline pharmacies. The convenience of online pharmacies is expected to drive growth in this segment[1].

Regional Analysis

• North America, Europe, Asia-Pacific: The market is geographically segmented into North America, Europe, Asia-Pacific, and the rest of the world. North America and Europe are currently the dominant regions due to higher healthcare spending and advanced medical infrastructure[1].

Key Players and Competition

The market for PEG3350-SOD SUL-NACL-KCL-ASCB-C is competitive, with several key players involved in the production and distribution of these formulations. The competition is driven by factors such as product quality, pricing, and marketing strategies.

Price Projections

• Current Pricing: The current pricing of PEG3350-SOD SUL-NACL-KCL-ASCB-C can vary based on the region, distribution channel, and the specific formulation. On average, a 4-liter jug of the reconstituted solution can range from $20 to $50[3][5].
• Future Pricing Trends: Given the projected market growth, prices are likely to remain stable or see a slight increase due to increased demand and potential advancements in formulation. However, competition and regulatory pressures could keep prices in check.

Factors Influencing Price

• Raw Material Costs: The cost of raw materials such as polyethylene glycol 3350, sodium sulfate, sodium chloride, potassium chloride, and ascorbic acid can impact the final product price.
• Regulatory Environment: Changes in regulatory requirements or policies can affect production costs and subsequently the market price.
• Market Demand: Increasing demand for bowel preparation solutions due to rising healthcare needs and an aging population can drive up prices.
• Competition: The level of competition among manufacturers and distributors influences pricing strategies.

Safety and Efficacy

• Common Adverse Reactions: The most common adverse reactions to PEG3350-SOD SUL-NACL-KCL-ASCB-C include nausea, abdominal fullness, bloating, abdominal cramps, and vomiting. These reactions are generally transient and subside rapidly[4].
• Contraindications and Warnings: Patients with certain conditions such as chronic diseases of the intestine, stomach, or throat, dehydration, difficulty swallowing, and heart disease should use this medication with caution. It is also important to avoid taking other medications by mouth starting 1 hour before taking this solution[2].

Pediatric and Geriatric Use

• Pediatric Use: The safety and effectiveness of PEG3350-SOD SUL-NACL-KCL-ASCB-C in pediatric patients aged 6 months and older are supported by clinical trials. However, use in children younger than 2 years should be carefully monitored for potential hypoglycemia and electrolyte imbalances[4].
• Geriatric Use: The medication is generally safe for geriatric patients, but they should be monitored for potential dehydration and electrolyte imbalances due to age-related health issues.

Storage and Handling

• Reconstitution and Storage: The powder must be reconstituted with water before use and stored in the refrigerator to improve taste. The solution should not be frozen, and any unused portion should be discarded 24 hours after mixing[4].

Conclusion

The market for PEG3350-SOD SUL-NACL-KCL-ASCB-C is poised for significant growth driven by increasing healthcare needs and advancements in medical procedures. While prices are expected to remain relatively stable, factors such as raw material costs, regulatory changes, and market demand will continue to influence pricing trends.

Key Takeaways

• The PEG 3350 market is projected to grow significantly by 2032.
• The medication is widely used for bowel preparation and constipation treatment.
• Prices are influenced by raw material costs, regulatory environment, market demand, and competition.
• The medication has common adverse reactions but is generally safe for most patients.
• Special precautions are necessary for pediatric and geriatric use.

FAQs

1. What is PEG3350-SOD SUL-NACL-KCL-ASCB-C used for?

PEG3350-SOD SUL-NACL-KCL-ASCB-C is used primarily to clean out the intestines before medical procedures such as colonoscopies and to treat constipation.

2. How is PEG3350-SOD SUL-NACL-KCL-ASCB-C administered?

The medication is administered as an oral solution after reconstituting the powder with water.

3. What are the common adverse reactions to PEG3350-SOD SUL-NACL-KCL-ASCB-C?

Common adverse reactions include nausea, abdominal fullness, bloating, abdominal cramps, and vomiting.

4. Can PEG3350-SOD SUL-NACL-KCL-ASCB-C be used in pediatric patients?

Yes, it can be used in pediatric patients aged 6 months and older, but use in children younger than 2 years should be carefully monitored.

5. How should PEG3350-SOD SUL-NACL-KCL-ASCB-C be stored?

The reconstituted solution should be stored in the refrigerator and discarded 24 hours after mixing.

Cited Sources

1. Market Research Future, "PEG 3350 Market Size, Share, Trends, Growth Forecast 2032".
2. BuzzRx, "Peg3350-Sod Sul-Nacl-Kcl-Asb-C Use Warnings".
3. BuzzRx, "Drug Details - Peg3350-Sod Sul-Nacl-Kcl-Asb-C".
4. Drugs.com, "PEG-3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride: Package Insert / Prescribing Info".
5. Kaiser Permanente, "peg3350 140 gram-sod sulfate 9 gram-NaCl 5.2gram-KCl-C oral pwdr packs".